Apolipoprotein E and cognitive decline in Alzheimer's disease

Neurology

Volumn 47, Issue 2, 1996, Pages 317-320

  Plassman, Brenda L ^a   Breitner, John C S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; COGNITIVE DEFECT; GENETICS; HUMAN; NOTE;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION DISORDERS; HUMANS;

EID: 0030210475     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.47.2.317     Document Type: Editorial

References (31)

1. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996;47:444-448.
2. Asada T, Kariya T, Yamagata Z, Kinoshita T, Asaka A. ApoE epsilon 4 allele and cognitive decline in patients with Alzheimer's disease. Neurology 1996;47:603.
3. Kurz A, Egensperger R, Haupt M, et al. Apolipoprotein E allele epsilon 4, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology 1996;47:440-443.
4. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995;45:1323-1328.
5. Basun H, Grut M, Winblad B, Lannfelt L. Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995;183:32-34.
6. Frisoni GB, Govoni S, Geroldi C, et al. Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 1995;37:596-604.
7. Edland SD, Kukull WA, Schellenberg GD, et al. Apolipoprotein E and rate of cognitive decline in Alzheimer's disease [abstract]. Neurology 1995;45(suppl 4):A213-A214.
8. Ohm TG, Muller H, Braak H, Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 1995;64:209-217.
9. Ohm TG, Kirca M, Bohl J, Scharnagl H, Grob W, Marz W. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 1995;66:583-587.
10. Breitner JCS, Welsh KA. Genes and recent developments in the epidemiology of Alzheimer's disease and related dementia. Epidemiol Rev 1995;17:39-47.
11. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer disease. Annu Rev Med 1996;47:387-400.
12. Reed T, Carmelli D, Swan GE, et al. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E E4 allele. Arch Neurol 1994;51:1189-1192.
13. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 1995;346:1387-1390.
14. Soininen H, Partanen K, Pitkanen A, et al. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E e4 allele. Neurology 1995;45:391-392.
15. Small GW, Mazziotta JC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. JAMA 1995;273:942-947.
16. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-1278.
17. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992;42:1681-1688.
18. Jobst KA, Smith AD, Szatmari M, et al. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet 1994;343:829-830.
19. Plassman BL, Welsh KA, Helms M, Brandt J, Page WF, Breitner JCS. Intelligence and education as predictors of cognitive state in late life: a 50 year follow-up. Neurology 1995;45:1446-1450.
20. Satz P. Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology 1993;7:273-295.
21. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993;43:12-20.
22. Stern Y, Tang MX, Denaro J, Mayeaux R. Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann Neurol 1995;37:590-595.
23. Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein E4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 1994;44:1513-1516.
24. Breitner JCS, Welsh KA, Gau BA, et al. Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of aging twin veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 1995;52:763-771.
25. Bergem ALM. Heredity in dementia of the Alzheimer type. Clin Genet 1994;46:144-149.
26. Zubenko GS, Stiffler S, Stabler S, et al. Association of the apolipoprotein E E4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet 1994;54:199-205.
27. Payami H, Kaye J, Heston LL, Bird TD, Schellenberg GD. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;342:738.
28. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein e4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 1994;7:74-78.
29. Sorbi S, Nacmias B, Forleo P, Piacentini S, Latorraca S, Amaducci L. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol 1995;38:124-127.
30. St. George-Hyslop P, Crapper-McLachlan D, Tuda T, et al. Alzheimer's disease and possible gene interaction. Science 1994;263:537.
31. De Lacoste MC, White CL. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol Aging 1993;14:1-16.